Viewing Study NCT06649695


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2025-12-25 @ 12:37 PM
Study NCT ID: NCT06649695
Status: RECRUITING
Last Update Posted: 2025-09-25
First Post: 2024-10-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
Sponsor: European Myeloma Network B.V.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module